Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
Crossref DOI link: https://doi.org/10.1245/s10434-014-4225-1
Published Online: 2014-10-31
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blazer, Marlo
Wu, Christina
Goldberg, Richard M.
Phillips, Gary
Schmidt, Carl
Muscarella, Peter
Wuthrick, Evan
Williams, Terrence M.
Reardon, Joshua
Christopher Ellison, E.
Bloomston, Mark
Bekaii-Saab, Tanios
Text and Data Mining valid from 2014-10-31